Welcome to Medications.com

Merck & Co: too little too late in osteoporosis market - Pharmaceutical Business Review

The reformulation of Fosamax to include vitamin D, marketed as Fosamax Plus D/Fosavance, was the most successful of these strategies, generating additional ...

http://www.pharmaceutical-busines... | Posted: Thu Feb 07 03:17:00 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea